Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Huangbai liquid coating is a topical Traditional Chinese Medicine (TCM) formulation primarily composed of extracts from *Phellodendron amurense* (Huangbai), *Gardenia jasminoides* (Zhizi), *Lonicera japonica* (Jinyinhua), *Taraxacum mongolicum* (Pugongying), and *Rehmannia glutinosa* (Dihuang). It is widely used in clinical practice for the treatment of various skin conditions, including acute and chronic wounds, wound infections, and localized inflammation of skin and soft tissues. The solution exerts its therapeutic effects through a combination of antibacterial, anti-inflammatory, and tissue-regenerative properties. *Phellodendron amurense*, a key ingredient, contains alkaloids such as berberine that inhibit bacterial growth and reduce inflammatory exudation. The formulation is typically applied as a topical solution or coating to promote wound healing and resolve local infection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on compound huangbai liquid coating.